Where does Zeltiq Aesthetics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Zeltiq Aesthetics, Inc. ranks #7,223 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Zeltiq Aesthetics, Inc. hold?

Zeltiq Aesthetics, Inc. holds 46 US utility patents granted between 2015 and 2025, spanning 12 technology areas.

What is Zeltiq Aesthetics, Inc.'s Innovation Score?

Zeltiq Aesthetics, Inc. has an Innovation Score of 41.5 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Zeltiq Aesthetics, Inc.'s patent grant rate increasing or decreasing?

Zeltiq Aesthetics, Inc.'s recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Zeltiq Aesthetics, Inc.'s patents?

Zeltiq Aesthetics, Inc.'s patents average 18.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Zeltiq Aesthetics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Zeltiq Aesthetics, Inc.

Q: What technology areas does Zeltiq Aesthetics, Inc. focus on?

Zeltiq Aesthetics, Inc.'s top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 41 patents. Grants appear in 12 CPC subclasses total.

USPTO PatentsView assignee record - 46 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Zeltiq ranks #7,223 of 50,000 tracked US assignees by granted-patent volume, with 46 patents across 12 technology areas.

#7,223
of 50,000 US assignees by volume: Top 33%
by Innovation Score (41.5/100): 18.4
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7223 · US Corporation #7,223 · 46 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 46 grants
UPPER-Q #7,223/50,000
PHOTO-FINISH i-PRO
CPC-FOCUS A61F · 12 areas
INNOV-PAR 41.5/100
CLAIMS-RICH 18.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: I-pro Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
New Balance Athletics · near

41
Reynolds Presto Prod… · near

41
Sony Europe · near

41
Varmour Networks · near

41
Zeltiq Aesthetics · this assignee

41
3D Lighting Innovati… · lowest

7

What this shows Zeltiq Aesthetics, Inc. stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-USCORP, VEL-SURGE, BOOK-FULL. Volume places it #7,223 of 50,000; Innovation Score 41.5/100 sits in the top 33% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is I-pro Co., Ltd. (±0 grants).

Portfolio overview

Zeltiq Aesthetics, Inc. has been granted 46 US utility patents between 2015 and 2025, placing Zeltiq Aesthetics, Inc. at #7,223 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.4 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Zeltiq Aesthetics, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Zeltiq sits between Yamashita Rubber Co., Ltd. (46 patents, rank #7,220) and AEHR TEST Systems (45 patents, rank #7,228) - the closest US assignees by grant volume. The composite Innovation Score of 41.5/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 30 grants, compared with 15 in the 2015–2019 window, a +100% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Zeltiq Aesthetics, Inc.'s 18.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 12 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Yamashita Rubber

46
ZF Wind Power Ant…

46
Zhejiang Sanhua I…

46
Zainar

46
i-pro

46
Zeltiq Aesthetics ◀

46
24/7 Customer

45
Ada-es

45
AEHR TEST Systems

45

What this shows Zeltiq holds 46 patents at rank #7,224, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Zeltiq

By rank, the assignees closest to #7,224 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in Zeltiq's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Zeltiq, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Reynolds Presto Products Inc. 41 Varmour Networks, Inc. 41 New Balance Athletics, Inc. 41 Sony Europe Limited 41

Zeltiq's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 33% higher than 67% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Zeltiq Aesthetics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	2.2%
2016	3	6.5%
2017	5	10.9%
2018	3	6.5%
2019	3	6.5%
2020	10	21.7%
2021	6	13.0%
2022	7	15.2%
2023	2	4.3%
2024	5	10.9%
2025partial year	1	2.2%

Which technologies does Zeltiq Aesthetics, Inc. patent most?

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 41

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 31

A61H - PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY 12

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 9

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 8

F16L - PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL 1

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 1

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1

A61Q - SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS 1

G05D - SYSTEMS FOR CONTROLLING OR REGULATING NON-ELECTRIC VARIABLES 1

C09J - ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES 1

H04L - TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION 1

Top 12 of 12 technology areas

Where it ranks

Overall rank by patents

#7,223

of 50,000 tracked assignees

Innovation Score

41.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.